Quetiapine at high doses for the treatment of refractory schizophrenia

被引:15
作者
Boggs, Douglas L. [1 ]
Kelly, Deanna L. [1 ]
Feldman, Stephanie [1 ]
McMahon, Robert P. [1 ]
Nelson, Matthew W. [2 ]
Yu, Yang [3 ]
Conley, Robert R. [4 ]
机构
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA
[2] Sanofi Aventis, Reg Med Liaison, Internal Med US Med Affairs, Bridgewater, MA USA
[3] Harris Corp, NHANES, Natl Ctr Hlth Stat, Hyattsville, MD USA
[4] Distinguished Eli Lilly Scholar, Indianapolis, IN USA
关键词
D O I
10.1016/j.schres.2008.01.013
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:347 / 348
页数:2
相关论文
共 8 条
[1]   EFFECT OF ANTIPSYCHOTIC WITHDRAWAL ON EXTRAPYRAMIDAL SYMPTOMS - STATISTICAL-METHODS FOR ANALYZING SINGLE-SAMPLE REPEATED-MEASURES DATA [J].
ARNDT, S ;
DAVIS, CS ;
MILLER, DD ;
ANDREASEN, NC .
NEUROPSYCHOPHARMACOLOGY, 1993, 8 (01) :67-75
[2]  
Breier AF, 1999, AM J PSYCHIAT, V156, P294
[3]   Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia [J].
Conley, RR ;
Kelly, DL ;
Nelson, MW ;
Richardson, CM ;
Feldman, S ;
Benham, R ;
Steiner, P ;
Khan, I ;
McMullen, R ;
Gale, E ;
Mackowick, M ;
Love, RC .
CLINICAL NEUROPHARMACOLOGY, 2005, 28 (04) :163-168
[4]  
Guy W., 1976, DHEW PUBLICATION
[5]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[6]  
Kane JA, 2003, J CLIN PSYCHIAT, V64, P5
[7]   Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: An open-label switch study [J].
Lindenmayer, JP ;
Czobor, P ;
Volavka, J ;
Lieberman, JA ;
Citrome, L ;
Sheitman, B ;
Chakos, M ;
McEvoy, JP .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (10) :931-935
[8]   High-dose quetiapine in treatment refractory schizophrenia [J].
Pierre, JM ;
Wirshing, DA ;
Wirshing, WC ;
Rivard, JM ;
Marks, R ;
Mendenhall, J ;
Sheppard, K ;
Saunders, DG .
SCHIZOPHRENIA RESEARCH, 2005, 73 (2-3) :373-375